Detalles de la búsqueda
1.
DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer.
Int J Mol Sci
; 24(3)2023 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36769317
2.
May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?
Int J Mol Sci
; 24(1)2022 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36613532
3.
Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC).
Int J Mol Sci
; 22(2)2021 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33477700
4.
BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects.
Int J Cancer
; 147(5): 1334-1342, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32022259
5.
Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.
Breast Cancer Res
; 20(1): 72, 2018 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29996899
6.
Correction to: Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.
Breast Cancer Res
; 24(1): 53, 2022 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35869494
7.
Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group.
Br J Cancer
; 117(2): 164-170, 2017 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28641315
8.
A Comparison of Three Methods for the Detection of Circulating Tumor Cells in Patients with Early and Metastatic Breast Cancer.
Cell Physiol Biochem
; 44(2): 594-606, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29161698
9.
Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients.
Breast Cancer Res
; 17: 113, 2015 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26285572
10.
ERCC1 SNPs as Potential Predictive Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy.
Cancer Invest
; 33(4): 107-13, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25647444
11.
Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer.
BMC Cancer
; 15: 399, 2015 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-25962645
12.
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.
Lancet Oncol
; 15(4): 406-14, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24636208
13.
Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy.
Breast Cancer Res
; 16(6): 485, 2014 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25432416
14.
Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer.
BMC Cancer
; 14: 651, 2014 Sep 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-25182808
15.
The journey of lung cancer patients from symptoms to diagnosis in Greece. A mixed methods approach.
NPJ Prim Care Respir Med
; 34(1): 5, 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38684681
16.
Corrigendum: MicroRNAs regulating tumor immune response in the prediction of the outcome in patients with breast cancer.
Front Mol Biosci
; 11: 1413164, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38715706
17.
A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The "ALARM" study.
Cancer Med
; 13(3): e6916, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38247106
18.
Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the IdyllaTM platform: a real-world two-center experience in Greece.
Expert Rev Mol Diagn
; 24(1-2): 89-98, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38193169
19.
Pemetrexed versus erlotinib in pretreated patients with advanced non-small cell lung cancer: a Hellenic Oncology Research Group (HORG) randomized phase 3 study.
Cancer
; 119(15): 2754-64, 2013 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23661337
20.
Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.
PLoS One
; 18(11): e0294382, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37943834